Cancer Institute A national cancer institute
designated cancer center

Donna Peehl, PhD

Publication Details

  • Serum Mac-2BP does not distinguish men with high grade, large volume prostate cancer from men with benign prostatic hyperplasia.

    Peehl DM, Chen Z, Nolley R. Prostate. 2011; 71 (1): 26-31

    Mac-2 binding protein (Mac-2BP) is a secreted protein that has been used as a serum prognostic marker for several types of cancers. A previous study showed that serum Mac-2BP was significantly higher (∼2-fold) in men with prostate cancer compared to healthy men. We investigated whether serum Mac-2BP could distinguish men with high grade, large volume prostate cancer from men with benign prostatic hyperplasia (BPH).

    PubMedID: 20583127

Stanford Medicine Resources:

Footer Links: